New ways to look at an old problem

Survey of Ophthalmology

Volumn 51, Issue 2, 2006, Pages 169-173

  Rebolleda, G ^a   Munoz Negrete F J ^a   Noval, S ^a   Contreras, I ^a   Gilbert, Molly E ^b,c   Sergott, Robert C ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Multiple sclerosis; Optic neuritis; Optical coherence tomography

Indexed keywords

BETA1A INTERFERON; INTERFERON; METHYLPREDNISOLONE; PLACEBO; PREDNISONE; STEROID;

AFFERENT PUPILLARY DEFECT; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG SAFETY; HISTOPATHOLOGY; HUMAN; MALE; MULTIPLE SCLEROSIS; NERVE COMPRESSION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC DISK; OPTIC NERVE; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PAPILLEDEMA; PRIORITY JOURNAL; REVIEW; VISUAL ACUITY; VISUAL FIELD;

EID: 33144485708     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2005.12.002     Document Type: Article

References (17)

1. _: Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis: PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet 352: 1498-504, 1998
2. R.W. Beck, P.A. Cleary, and J.D. Trobe The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group N Engl J Med 329 1993 1764 1769
3. R.W. Beck, J.D. Trobe, and P.S. Moke High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial Arch Ophthalmol 121 2003 944 949
4. R.W. Beck, and J.D. Trobe What we have learned from the Optic Neuritis Treatment Trial Ophthalmology 102 1995 1504 1508
5. A.F. Fercher, C.K. Hitzenberger, and W. Drexler In vivo optical coherence tomography Am J Ophthalmol 116 1993 113 114
6. R. Foroozan, L.M. Buono, and P.J. Savino Acute demyelinating optic neuritis Curr Opin Ophthalmol 13 2002 375 380
7. M. Inglese, A. Ghezzi, and S. Bianchi Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves Arch Neurol 59 2002 250 255
8. L.D. Jacobs, R.W. Beck, and J.H. Simon Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group N Engl J Med 343 2000 898 904
9. A. Kanamori, M. Nakamura, and M.F. Escano Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography Am J Ophthalmol 135 2003 513 520
10. J.B. Kerrison, T. Flynn, and W.R. Green Retinal pathologic changes in multiple sclerosis Retina 14 1994 445 451
11. D.K. Li, and D.W. Paty Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multi Ann Neurol 46 1999 197 206
12. H. Panitch, D.S. Goodin, and G. Francis Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial Neurology 59 2002 1496 1506
13. V. Parisi, G. Manni, and M. Spadaro Correlation between morphological and functional retinal impairment in multiple sclerosis patients Invest Ophthalmol Vis Sci 40 1999 2520 2527
14. B.D. Trapp, J. Peterson, and R.M. Ransohoff Axonal transection in the lesions of multiple sclerosis N Engl J Med 338 1998 278 285
15. S.A. Trip, P.G. Schlottmann, and S.J. Jones Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis Ann Neurol 58 2005 383 391
16. L. Truyen, J.H. van Waesberghe, and M.A. van Walderveen Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis Neurology 47 1996 1469 1476
17. M.A. van Walderveen, W. Kamphorst, and P. Scheltens Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis Neurology 50 1998 1282 1288